Radiopharm Theranostics Ltd (RADX) stock
RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
$0.63−0.04 (-6.33%)
Close on Nov 20, 2026Market cap $7.45MP/E –Yield –
Radiopharm Theranostics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2026 it was $263.39K, up 570.6% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $263.39K | +570.6% |
| FY2025 | Jun 30, 2025 | $39.28K | -86.9% |
| FY2024 | Jun 30, 2024 | $299.23K | +2.3% |
| FY2023 | Jun 30, 2023 | $292.36K | – |
See a number that looks wrong?